Clinical Trial Update: Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia [Phase 1, Phase 2]

View source ↗

Summary

This update reports a completed Phase 1/2 clinical trial evaluating stem cell therapy to promote vasculogenesis in patients with severe myocardial ischemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Myocardial Ischemia

Drugs mentioned

• Stem cell therapy (stem cell)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Myocardial Ischemia, Coronary Heart Disease | Phase 1, Phase 2 | Status: COMPLETED